healtheconomics.com
21st Century Cures and Off-Label Promotion Benefit HEOR and Drug Safety
As my writing for the AdverseEvents Blog can attest, I’m in favor of data transparency. In my view, no organization should have monopolistic control over important information that limits the abili…